Investments
76Portfolio Exits
3Funds
5About Inventages Venture Capital
Inventages Venture Capital Investment, founded in 2000 and based in Geneva, Switzerland, is a corporate private equity and venture capital arm run by Nestle. Inventages focuses on financing companies across a broad spectrum of companies including PIPES, seed, early, mid, late venture, growth, and buyouts financing. In terms of industry focus, Inventages seeks to invest in life sciences and biotechnology, drugs, OTC and medical foods, nutrition, functional foods, nutraceuticals and dietary supplements, cosmeceuticals, health and wellness brands, enabling technologies and services, and diagnostics and medical devices. Geographically, the firm looks for opportunities globally and seeks to generally invest $8 million to $10 million initially with a total investment size of $10 million to $15 million over the life of the investment. The firm seeks to be a lead investor in positions it takes and also aims to take Board seats. Inventages also has offices in Nassau, The Bahamas; London, United Kingdom; and Auckland, NewZealand.
Want to inform investors similar to Inventages Venture Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Inventages Venture Capital
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Inventages Venture Capital in 1 Expert Collection, including Vitamin & Supplement Startups.
Vitamin & Supplement Startups
237 items
Research containing Inventages Venture Capital
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Inventages Venture Capital in 2 CB Insights research briefs, most recently on Aug 9, 2021.
Latest Inventages Venture Capital News
Sep 2, 2016
2 September 2016 Nestlé to swallow portfolio company Phagenesis Phagenesis, developer of a medical device to treat dysphagia, had raised about $20m from investors including Nestlé's Inventages Venture Capital unit. Author: Robert Lavine, News Editor Nestlé Health Science, a subsidiary of food and nutrition product maker Nestlé, agreed yesterday to acquire UK-based medical device producer Phagenesis, allowing Nestlé-backed venture firm Inventages Venture Capital to exit. This rest of this content is only accessible to Global Corporate Venturing Subscribers This content is only accessible to subscribers. If you are a subscriber,please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Inventages Venture Capital Investments
76 Investments
Inventages Venture Capital has made 76 investments. Their latest investment was in Cerecin as part of their Series I on August 8, 2022.
Inventages Venture Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/16/2022 | Series I | Cerecin | $7.22M | No | Inventages Venture Capital, and Undisclosed Investors | 1 |
9/14/2021 | Series H - II | Cerecin | $30M | No | 2 | |
2/5/2021 | Series H | Cerecin | $10M | No | Inventages Venture Capital, Meriwether Capital, Undisclosed Investors, and ViroPharma | 1 |
6/15/2020 | Series D | |||||
10/4/2018 | Series G |
Date | 8/16/2022 | 9/14/2021 | 2/5/2021 | 6/15/2020 | 10/4/2018 |
|---|---|---|---|---|---|
Round | Series I | Series H - II | Series H | Series D | Series G |
Company | Cerecin | Cerecin | Cerecin | ||
Amount | $7.22M | $30M | $10M | ||
New? | No | No | No | ||
Co-Investors | Inventages Venture Capital, and Undisclosed Investors | Inventages Venture Capital, Meriwether Capital, Undisclosed Investors, and ViroPharma | |||
Sources | 1 | 2 | 1 |
Inventages Venture Capital Portfolio Exits
3 Portfolio Exits
Inventages Venture Capital has 3 portfolio exits. Their latest portfolio exit was Phagenesis on September 01, 2016.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/1/2016 | Acquired | 3 | |||
Date | 9/1/2016 | ||
|---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 3 |
Inventages Venture Capital Acquisitions
2 Acquisitions
Inventages Venture Capital acquired 2 companies. Their latest acquisition was Mixt Greens on July 17, 2009.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
7/17/2009 | Acq - Fin | |||||
3/17/2009 |
Date | 7/17/2009 | 3/17/2009 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin | |
Sources |
Inventages Venture Capital Fund History
5 Fund Histories
Inventages Venture Capital has 5 funds, including Inventages IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
10/15/2005 | Inventages IV | Multi-Stage Venture Capital | Closed | $601.05M | 1 |
10/15/2004 | Inventages III | ||||
3/5/2002 | Inventages II | ||||
Inventages I | |||||
Inventages V |
Closing Date | 10/15/2005 | 10/15/2004 | 3/5/2002 | ||
|---|---|---|---|---|---|
Fund | Inventages IV | Inventages III | Inventages II | Inventages I | Inventages V |
Fund Type | Multi-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | $601.05M | ||||
Sources | 1 |
Inventages Venture Capital Team
4 Team Members
Inventages Venture Capital has 4 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Gunnar Weikert | Founder | Current | |
Name | Gunnar Weikert | |||
|---|---|---|---|---|
Work History | ||||
Title | Founder | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.